The effect of anaesthesia and surgery on plasma cytokine production

Anaesthesia

Volumn 54, Issue 8, 1999, Pages 733-738

  Helmy, S A K ^a   Wahby, M A M ^a   El Nawaway, M ^a  

^a NONE

Author keywords

Immune system; cytokine production; Surgery; cholecystectomy

Indexed keywords

ATRACURIUM; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTRAVENOUS ANESTHETIC AGENT; NEUROMUSCULAR BLOCKING AGENT; PROPOFOL; SUFENTANIL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANESTHESIA; ARTICLE; BLOOD LEVEL; CHOLECYSTECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTIVE SURGERY; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; MALE; SURGERY;

ADULT; ANESTHETICS, COMBINED; ANESTHETICS, INTRAVENOUS; ATRACURIUM; CHOLECYSTECTOMY; CHOLECYSTECTOMY, LAPAROSCOPIC; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKINS; MALE; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROPOFOL; SUFENTANIL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032802193     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.1999.00947.x     Document Type: Article

References (37)

1. Stevenson GW, Hall SC, Rudnick S, et al. The effect of anaesthetic agents on the human immune response. Anesthesiology 1990; 72: 542-52.
2. Gunzenhaeuser L, Moudgil GC, Mathieu A. Anaesthesia and the immune response. Bailliere's Clinical Anaesthesiology 1991; 5: 61-74.
3. Moudgil GC. Update on anaesthesia and the immune response. Canadian Anaesthesia Society Journal 1986; 33: S54-60.
4. Walton B. Effects of anaesthesia and surgery on immune status. British Journal of Anaesthesia 1979; 51: 37-43.
5. Koenig A, Koenig UD, Heicappel R, Stoeckel H. Differences in lymphocyte mitogenic stimulation pattern depending on anaesthesia and operative trauma: I. Halothane-nitrous oxide anaesthesia. European Journal of Anaesthesiology 1987; 4: 17-24.
6. Sheeran P, Hall GM. Cytokines in anaesthesia. British Journal of Anaesthesia 1997; 78: 201-19.
7. Bendtzen K. Clinical significance of cytokines, natural and therapeutic regulation. Seminars in Clinical Immunology 1991; 3: 5-13.
8. Marks JD, Marks CB, Luce JM, et al. Plasma tumor necrosis factor in patients with septic shock. American Review of Respiratory Diseases 1990; 141: 94-7.
9. Dofferhoff ASM, Bom VJJ, de Vries-Hospers HG, et al. Patterns of cytokines, plasma endotoxins, plasminogen activator inhibitor and acute phase proteins during the treatment of severe sepsis in humans. Critical Care Medicine 1992; 20: 185-92.
10. Cruse PJE, Foord R. A five year prospective study of 23,649 surgical wounds. Archives of Surgery 1973; 107: 206-9.
11. 2. New York: Elsevier Science, 1985; 259-62.
12. Pirttikangas C-O, Salo M, Mansikka M, et al. The influence of anaesthetic technique upon the immune response to hysterectomy. Anaesthesia 1995; 50: 1056-61.
13. Crozier TA, Muller JE, Quittkat D, et al. Effect of anaesthesia on the cytokine responses to abdominal surgery. British Journal of Anaesthesia 1994; 72: 280-5.
14. Peterson PK, Sharp B, Gekker G, et al. Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. Journal of Clinical Investigation 1987; 80: 824-31.
15. Gilliland HE, Armstrong MA, Carabine U, McMurray TJ. The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery. Anesthesia and Analgesia 1997; 85: 1394-8.
16. McBride WT, Armstrong MA, Crockard AD, et al. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. British Journal of Anaesthesia 1995; 75: 724-33.
17. Beutler B, Cerami A. Cachectin: more than a tumour necrosis factor. New England Journal of Medicine 1987; 316: 379-85.
18. Dinarello CA. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. Journal of Infectious Diseases 1991; 163: 1177-84.
19. Beutler B, Cerami A. The common mediator of shock, cachexia and tumor necrosis. Advances in Immunology 1988; 42: 213-31.
20. Pujol-Borrel R, Todd I, Doshi M, et al. HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature (London) 1987; 326: 304-6.
21. Offner F, Philippe J, Vogelaers D, et al. Serum tumor necrosis factor levels in patients with infectious disease and septic shock. Journal of Laboratory Clinical Medicine 1990; 116: 100-5.
22. Girardin E, Roux-Lombard P, Grau GE, et al. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group. Immunology 1992; 76: 20-3.
23. Cruickshank AM, Fraser WD, Burns HJG, et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clinical Science 1990; 79: 161-5.
24. Joris J, Cigarini I, Legrand M, et al. Metabolic and respiratory changes after cholecystectomy performed via laparotomy or laparoscopy. British Journal of Anaesthesia 1992; 69: 341-5.
25. Jakeways MSR, Mitchell V, Hashim IA, et al. Metabolic and inflammatory responses after open or laparoscopic cholecystectomy. British Journal of Surgery 1994; 81: 127-31.
26. Shenkin A, Fraser WD, Series J, et al. The serum interleukin-6 response to elective surgery. Lymphokine Research 1989; 8: 123-7.
27. Whitten CW, Hill GE, Ivy R, et al. Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery? Anesthesia and Analgesia 1998; 86: 28-33.
28. Haeffner-Cavaillon BN, Roussellier N, Ponzio O, et al. Induction of interleukin-1 production in patients undergoing cardiopulmonary by pass. Journal of Thoracic and Cardiovascular Surgery 1989; 98: 1100-6.
29. Munoz C, Conejero R, Caturla J, et al. Inhibition of cytokine production in cardiopulmonary by pass. Clinical Intensive Care 1992; 3(Suppl 3); 52.
30. Faist E, Ertel W, Mewes A, et al. Trauma-induced alterations of lymphokine cascade. In: Faist E, Ninnemann JL, Green D, eds. The Immune Consequences of Trauma, Shock and Sepsis. Berlin: Springer-Verlag, 1989; 79-94.
31. Faist E, Markewitz A, Schinkel C, et al. Trauma-induced alterations of cytokine synthesis patterns: mechanisms and modulatory interventions. In: Oppenheim JJ, Rossio JL, Gearing AJH, eds. Clinical Applications of Cytokines. New York: Oxford University Press, 1993; 337-45.
32. Ertel W, Faist E, Nestle C, et al. Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. Journal of Surgical Research 1990; 48: 622-8.
33. Ashcroft GS, Masterson GR. Interleukin-6 and wound healing [letter]. British Journal of Anaesthesia 1994; 73: 426.
34. Kaplan E, Dinarello CA, Wakabayashi G, et al. Interleukin-1 pretreatment protects against endotoxin-induced hypotension in rabbits: association with decreased tumor necrosis factor levels. Journal of Infectious Diseases 1993; 167: 244-7.
35. Alexander HR, Sheppard BC, Jensen JC, et al. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension and hypothermia of gram-negative sepsis. Journal of Clinical Investigation 1991; 88: 34-9.
36. Beilin B, Shavit Y, Hart J, et al. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesthesia and Analgesia 1996; 82: 492-7.
37. Markovic SN, Knight PR, Murasko DM. Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane. Anesthesiology 1993; 78: 700-6.